TP53 and breast carcinoma: Moreover, in vivo studies in a mice tumor model with the transgenic MMTV-neu spontaneous breast cancer that develops p53 misfolding corroborated the findings that ZnCl2 reactivates misfolded p53 proteins and enhances antitumor effects of chemotherapy [12].